NCT06112353View on ClinicalTrials.gov

Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection

PHASE4RecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

April 17, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2026

Conditions
Intestinal Disease
Interventions
DRUG

Neostigmine Injectable Solution

Examine GI-2 recovery

DRUG

Sugammadex injection

Examine GI-2 recovery

Trial Locations (1)

92868

RECRUITING

UC Irvine Medical Center, Orange

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of California, Irvine

OTHER